Artelo Biosciences (ARTL) Debt Ratio (2017 - 2026)
Artelo Biosciences' (ARTL) Debt Ratio came in at 0.04 for Q1 2026, down 75.9% from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Debt Ratio (2017 - 2026) Analysis & Trends
For FY2025, Artelo Biosciences' Debt Ratio stood at 0.16.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 0.33 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.23 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 0.55 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 0.41 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -0.06 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 0.56 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 0.51 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.31 |
| 10 | Artelo Biosciences | 49.32 Mn | 32.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 0.04 |
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | 0.18 |
| May 31, 2017 | 0.13 |
| Feb 28, 2017 | 2.20 |
API Access
Artelo Biosciences Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();